Clinical trials
Type 2 Diabetes Treated With Insulin clinical trials
Below are recruiting type 2 diabetes treated with insulin clinical trials, each written for real people, not researchers. We’re tracking 119 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07262788Recruiting
Lifestyle program for recently diagnosed type 2 diabetes
This study tests whether a carefully guided lifestyle program (diet and exercise) can help people who were recently diagnosed with type 2 diabetes achieve remission—meaning their blood sugar stays normal without medication. You may be a good fit if you are overweight, not on insulin, and have had diabetes for less than 6 years.
Herlev, DenmarkAges 18–75 - NCT07193459RecruitingPhase 3
Study of an oral tablet for type 2 diabetes
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
Beijing, Beijing MunicipalityAges 18–75 - NCT07197788Enrolling by invitation
Continued access to the Endogenex device study for type 2 diabetes
This trial offers continued access to the Endogenex system for people who were in the sham (placebo) group of the ReCET study and have completed their 12-month visit. It tests a device that treats the duodenum to improve blood sugar control.
Miami, FloridaAges 22 years+ - NCT06864546Recruiting
Diabetes glucose tracking study for people not on insulin
This study tests a new way to help people with type 2 diabetes track their blood sugar in everyday life. It aims to see if a simple, patient-friendly approach can improve glucose control without needing insulin.
Pavia, PaviaAges 40–70 - NCT07165223RecruitingPhase 3
Testing a new insulin for type 2 diabetes
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
Linyi, ShandongAges 18 years+ - NCT03987308Recruiting
Test shot medicine versus insulin pump for new type 2 diabetes
This study compares a continuous “under the skin” diabetes medicine (called beinaglutide) with an insulin pump (CSII) in people who were recently diagnosed with type 2 diabetes. It aims to see which approach works better and is safer for controlling blood sugar.
Beijing, Beijing MunicipalityAges 18–70 - NCT07118475Enrolling by invitationEarly Phase 1
Islet transplant for type 2 diabetes
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
ShanghaiAges 18–75 - NCT07121504Recruiting
Hybrid closed-loop insulin for blood sugar control during surgery
This trial tests a smart insulin pump system (hybrid closed-loop) to control blood sugar in people with type 2 diabetes who need surgery and will receive nutrition through a vein. It aims to prevent high and low blood sugar during and after surgery.
Changsha, HunanAges 18 years+ - NCT06966427Recruiting
Using a dosing app for insulin management
This trial studies a smartphone system that helps people with diabetes decide how much insulin to take. It is for people who use insulin injections or are starting basal insulin, and it uses a continuous glucose monitor to guide dosing.
Petah TikvaAges 6–75 - NCT07097818Recruiting
GLITTER Study: Better Blood Sugar Control in Type 1 Diabetes
This study tests a program to help people with type 1 diabetes improve their blood sugar control using continuous glucose monitors, insulin pumps, and education sessions. It includes remote monitoring and camp activities for some participants.
Beijing, Beijing MunicipalityAges 6 years+ - NCT07082114RecruitingPhase 3
Testing a new tablet for type 2 diabetes
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
Yueyang, HunanAges 18–75 - NCT07083336Recruiting
Diet study for type 2 diabetes with fatty liver disease
This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.
Yichang, HubeiAges 18 years+ - NCT07060456RecruitingPhase 3
New drug for type 2 diabetes with insulin
This trial tests a new medicine called HRS9531 for people with type 2 diabetes who already use basal insulin. It aims to see if adding this drug helps control blood sugar better.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07061301Recruiting
Leaving the hospital with insulin: a transition study
This study helps people with type 2 diabetes who just started using insulin in the hospital get ready to go home. It tests whether extra support and tools like a smart insulin cap and a continuous glucose monitor make the switch safer and easier.
Valencia, ValenciaAges 18–70 - NCT06989723RecruitingPhase 4
Pioglitazone and empagliflozin for fatty liver in type 2 diabetes
This trial tests two diabetes pills (pioglitazone and empagliflozin) to see if they can reduce liver fat in people with type 2 diabetes and fatty liver disease. It may help if your diabetes is not well controlled and you have a fatty liver confirmed by a special ultrasound scan.
Seongnam-siAges 20 years+ - NCT07038473Recruiting
Early detection of type 1 diabetes in relatives
This study screens brothers, sisters, and children of people with type 1 diabetes to find early signs of the disease before symptoms appear. The goal is to catch it early and offer monitoring or future prevention options.
Kuwait City, Al Asimah / Capital GovernorateAges 1.5 years–18 years - NCT07007676Recruiting
Continuous glucose monitor for older adults with type 2 diabetes
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
Shenzhen, GuandongAges 60 years+ - NCT07005986Recruiting
Pyrophosphate as a biomarker for artery hardening in type 2 diabetes
This study looks at a substance in the blood called pyrophosphate that may help doctors detect a type of artery hardening (mediacalcinosis) in people with type 2 diabetes. It tests whether this substance can be a useful early warning sign.
Nice, FranceAges 40–70 - NCT07011147Recruiting
Real-world test of automated insulin delivery in primary care
This study tests if an automated insulin delivery system (the iLet bionic pancreas) works well in real-world primary care settings for people with type 1 or type 2 diabetes. It aims to see if this technology can help manage blood sugar more easily.
Aurora, ColoradoAges 18–89 - NCT06976619RecruitingPhase 2
Blood sugar control and a diabetes drug on insulin production
This study looks at how blood sugar control and a class of drugs called GLP-1 agonists (like Ozempic) affect insulin-making cells in people with type 1 or type 2 diabetes who use insulin.
Rochester, MinnesotaAges 25–70 - NCT06738849Recruiting
Testing an app for insulin dosing
This trial tests the EkiYou smartphone app to help calculate your mealtime insulin dose. You need to have diabetes, use both a long-acting and a short-acting insulin pen, and be comfortable with a CGM and a smartphone.
BobignyAges 18 years+ - NCT06923644Recruiting
Personalized nutrition plan to prevent metabolic disease
This study tests whether a personalized nutrition plan based on your unique metabolism can help prevent chronic metabolic diseases like type 2 diabetes. You will follow a tailored diet and have your health monitored over time.
MaastrichtAges 40–75 - NCT06904846Enrolling by invitation
Testing a new continuous glucose monitor for 60 days
This study tests a new continuous glucose monitor (CGM) called iCan o3 that you wear on your abdomen for 60 days. It helps track your blood sugar levels continuously, so you and your doctor can see patterns and make better decisions about your diabetes care.
AntwerpAges 18–75 - NCT06902077Recruiting
Low-carb diet for teens with type 2 diabetes
This trial tests if a low-carb diet helps teens with type 2 diabetes manage their blood sugar. It may lead to better control without needing insulin.
Birmingham, AlabamaAges 12–18
Hear when a new Type 2 Diabetes Treated With Insulin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes treated with insulin?
- Yes. Clin2 currently lists 119 recruiting type 2 diabetes treated with insulin studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes treated with insulin trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes treated with insulin trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.